EXAS vs TFSL · rev $2.76B vs P/E 49, rev $595.4M
EXACT Sciences Corporation (EXAS) versus TFS Financial Corporation (TFSL) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
TFS Financial Corporation (TFSL) is a banks - regional company listed on NASDAQ.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported TFSL revenue for 2026-06-30 was $595.4M. Net income was $76.1M. Revenue was up 51.4% from 2026-03-31 to 2026-06-30. TFSL currently screens at market cap $4.56B and trailing P/E 49.3.
EXAS currently screens at market cap $20.03B. TFSL currently screens at market cap $4.56B and trailing P/E 49.3.
Not investment advice. Open the EXAS and TFSL stock pages for the full models.
Not investment advice.